BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.32.0//EN
X-ORIGINAL-URL:https://www.occitanie-innov.com/
X-WR-CALNAME:Occitanie Innov
X-WR-CALDESC:
X-WR-TIMEZONE:Europe/Paris
BEGIN:VTIMEZONE
TZID:Europe/Paris
X-LIC-LOCATION:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=4SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-c7b3f097f4810cbb3c4b18c09ab893bc@occitanie-innov.com
DTSTART;TZID=Europe/Paris:20240620T000100
DTEND;TZID=Europe/Paris:20240621T235900
DTSTAMP:20260129T123323Z
CREATED:20260129
LAST-MODIFIED:20260129
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:12th Antibody Industrial Symposium – AIS 2024
DESCRIPTION:Occitanie Innovation Biotherapy is a partner of the 12th Antibody Industrial Symposium (AIS2024).\nThe 12th AIS2024 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, will be held on June 20-21 2024, in Montpellier, France.\nThe AIS2024 is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more! This year’s 2-days-programme is organized into several tracks covering the hot topics in antibody, recombinant proteins, CART cells and other biopharmaceuticals research and development. Moreover, the program will allow opportunities for one-to-one meetings, companies to showcase their new products and technologies virtually as well as dedicated time for business partnering.\nSubmit your Abstract to give a Pitch presentation or present your Poster at the AIS2024. Abstract submission deadline is April 12th, 2024! Check guideline HERE\n Registration\nmAbs, bi- multi-specifics, Immunotherapy, developability, Ab-like molecules, immunocytokines, adoptive cell therapy, CAR-T cells, drug discovery, ADCs, analytics, patient stratification, PK/PD, AI & Machine Learning, bioprocessing\nMore information about AIS 2024\nHome\n\nContact\nAna Sofia Antunes – Head of International Affairs, Scientific Events & Communication ana-sofia.antunes@mabdesign.fr I Tel. +33 (0)6 26 33 63 21\n
URL:https://www.occitanie-innov.com/events/12th-antibody-industrial-symposium-ais-2024/
CATEGORIES:Biotherapy (en)
ATTACH;FMTTYPE=image/png:https://www.occitanie-innov.com/wp-content/uploads/2026/01/AIS2024-1240X620.png
END:VEVENT
END:VCALENDAR